Literature DB >> 21144709

Comparison of oral versus sublingual piroxicam during postoperative pain management after lower third molar extraction.

P A K Trindade1, F P M Giglio, B L Colombini-Ishikiriama, A M Calvo, K C S Modena, D A Ribeiro, T J Dionísio, D T Brozoski, J R P Lauris, F A C Faria, C F Santos.   

Abstract

In this study, 53 patients received piroxicam, administered orally or sublingually, after undergoing removal of symmetrically positioned lower third molars, during two separate appointments. This study used a randomized, blind, cross-over protocol. Objective and subjective parameters were recorded for comparison of postoperative results for 7 days after surgery. Patients treated with oral or sublingual piroxicam reported low postoperative pain scores. The patients who received piroxicam orally took a similar average amount of analgesic rescue medication compared with patients who received piroxicam sublingually (p>0.05). Patients exhibited similar values for mouth opening measured just before surgery and immediately following suture removal 7 days later (p>0.05), and showed no significant differences between routes of piroxicam administration for swelling control during the second or seventh postoperative days (p>0.05). In summary, pain, trismus and swelling after lower third molar extraction, independent of surgical difficulty, could be controlled by piroxicam 20mg administered orally or sublingually and no significant differences were observed between the route of delivery used in this study.
Copyright © 2010 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21144709     DOI: 10.1016/j.ijom.2010.10.026

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  4 in total

1.  CYP450 polymorphisms and clinical pharmacogenetics of ibuprofen after lower third molar extraction.

Authors:  Giovana M Weckwerth; Thiago J Dionísio; Yuri M Costa; Bella L Colombini-Ishiquiriama; Gabriela M Oliveira; Elza A Torres; Leonardo R Bonjardim; Adriana M Calvo; Troy Moore; Devin M Absher; Carlos F Santos
Journal:  Eur J Clin Pharmacol       Date:  2020-11-17       Impact factor: 2.953

2.  Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor.

Authors:  Yi Tan; Ping Li
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

3.  Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9.

Authors:  Adriana Maria Calvo; Paulo Zupelari-Gonçalves; Thiago José Dionísio; Daniel Thomas Brozoski; Flávio Augusto Faria; Carlos Ferreira Santos
Journal:  J Pain Res       Date:  2017-07-06       Impact factor: 3.133

4.  Multifocal Analysis of Acute Pain After Third Molar Removal.

Authors:  Giovana Maria Weckwerth; Thiago José Dionísio; Yuri Martins Costa; Paulo Zupelari-Gonçalves; Gabriela Moraes Oliveira; Elza Araújo Torres; Leonardo Rigoldi Bonjardim; Flavio Augusto Cardoso Faria; Adriana Maria Calvo; Troy Moore; Devin Michael Absher; Carlos Ferreira Santos
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.